169
Views
46
CrossRef citations to date
0
Altmetric
Miscellaneous

Papillomavirus-like particle based vaccines: cervical cancer and beyond

&
Pages 571-581 | Published online: 23 Feb 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ian Frazer. (2004) Is vaccine therapy the future in cancer prevention?. Expert Opinion on Pharmacotherapy 5:12, pages 2427-2434.
Read now
N Randall Chu. (2003) Therapeutic vaccination for the treatment of mucosotropic human papillomavirus-associated disease. Expert Opinion on Biological Therapy 3:3, pages 477-486.
Read now

Articles from other publishers (44)

Shu Chen, Guoying Ni, Xiaolian Wu, Bin Zhu, Zaowen Liao, Yuejian Wang & Xiaosong Liu. (2016) Blocking IL-10 signalling at the time of immunization renders the tumour more accessible to T cell infiltration in mice. Cellular Immunology 300, pages 9-17.
Crossref
Yan Wang, Qinglong Shang, Weizhen Xu, Di Li, Hongxi Gu & Lanlan Wei. (2014) Characterization of two new monoclonal antibodies against human papillomavirus type 16 L1 protein. Diagnostic Pathology 9:1.
Crossref
Burki Rajendar, Vuppu Sivakumar, Rajan Sriraman, Mohammed Raheem, Rajendra Lingala & Ramesh V. Matur. (2013) A simple and rapid method to monitor the disassembly and reassembly of virus-like particles. Analytical Biochemistry 440:1, pages 15-17.
Crossref
MH Itani & I Uthman. (2012) Letter to the Editor. Lupus 21:12, pages 1370-1371.
Crossref
Franco Borruto & Ciro Comparetto. 2012. HPV and Cervical Cancer. HPV and Cervical Cancer 273 326 .
Diana V. Pastrana, Katherine A. Pumphrey, Nicolas ?uburu, Rachel M. Schowalter & Christopher B. Buck. (2010) Characterization of monoclonal antibodies specific for the Merkel cell polyomavirus capsid. Virology 405:1, pages 20-25.
Crossref
Rongxin Zhang, Sheng Zhang, Min Li, Changyi Chen & Qizhi Yao. (2010) Incorporation of CD40 ligand into SHIV virus-like particles (VLP) enhances SHIV-VLP-induced dendritic cell activation and boosts immune responses against HIV. Vaccine 28:31, pages 5114-5127.
Crossref
James P. Nataro & Myron M. Levine. 2010. Topley & Wilson's Microbiology and Microbial Infections. Topley & Wilson's Microbiology and Microbial Infections.
Lutz Gissmann, Lysann Schädlich & Tilo Senger. (2009) Papillomviren und Krebs. Wie aus einem Anfangsverdacht ein Impfstoff wurde. Biologie in unserer Zeit 39:1, pages 22-29.
Crossref
Caroline Le Poole, Cecele J. Denman & Jack L. Arbiser. (2008) Immunosuppression may be present within condyloma acuminata. Journal of the American Academy of Dermatology 59:6, pages 967-974.
Crossref
Katarzyna BandurskaRobert BrodzikSergei SpitsinThomas KohlCarla PortocarreroYuri SmirnovNatalia PogrebnyakAgnieszka SirkoHilary KoprowskiMaxim Golovkin. (2008) Plant-produced Hepatitis B Core Protein Chimera Carrying Anthrax Protective Antigen Domain-4. Hybridoma 27:4, pages 241-247.
Crossref
Tao Bian, Yue Wang, Zhenhua Lu, Zhenmei Ye, Li Zhao, Jiao Ren, Hui Zhang, Li Ruan & Houwen Tian. (2008) Human papillomavirus type 16 L1E7 chimeric capsomeres have prophylactic and therapeutic efficacy against papillomavirus in mice. Molecular Cancer Therapeutics 7:5, pages 1329-1335.
Crossref
M. MANAVI, G. HUDELIST, A. FINK-RETTER, D. GSCHWANTLER-KAULICH, K. PISCHINGER & K. CZERWENKA. (2008) Human papillomavirus DNA integration and messenger RNA transcription in cervical low- and high-risk squamous intraepithelial lesions in Austrian women. International Journal of Gynecological Cancer 18:2, pages 285-294.
Crossref
Alison A. McCormick, Tina A. Corbo, Sherri Wykoff-Clary, Long V. Nguyen, Mark L. Smith, Kenneth E. Palmer & Gregory P. Pogue. (2006) TMV-peptide fusion vaccines induce cell-mediated immune responses and tumor protection in two murine models. Vaccine 24:40-41, pages 6414-6423.
Crossref
Jiahua Qian, Yujun Dong, Yuk‐Ying S. Pang, Ramy Ibrahim, Jay A. Berzofsky, John T. Schiller & Samir N. Khleif. (2006) Combined prophylactic and therapeutic cancer vaccine: Enhancing CTL responses to HPV16 E2 using a chimeric VLP in HLA‐A2 mice. International Journal of Cancer 118:12, pages 3022-3029.
Crossref
Chester Q. LiElizabeth SoistmanDaniel C. Carter. (2006) Ferritin nanoparticle technology... A new platform for antigen presentation and vaccine development . Industrial Biotechnology 2:2, pages 143-147.
Crossref
Emma J. CrosbieHenry C. Kitchener. (2006) Human papillomavirus in cervical screening and vaccination. Clinical Science 110:5, pages 543-552.
Crossref
Alfonso J. García-Piñeres, Allan Hildesheim, Matthew Trivett, Marcus Williams, Li Wu, Vineet N. KewalRamani & Ligia A. Pinto. (2006) Role of DC-SIGN in the activation of dendritic cells by HPV-16 L1 virus-like particle vaccine. European Journal of Immunology 36:2, pages 437-445.
Crossref
Yao-Chi Chung. (2006) Expression, purification and characterization of enterovirus-71 virus-like particles. World Journal of Gastroenterology 12:6, pages 921.
Crossref
Zhengrong Cui & Leaf Huang. (2005) Liposome-polycation-DNA (LPD) particle as a carrier and adjuvant for protein-based vaccines: Therapeutic effect against cervical cancer. Cancer Immunology, Immunotherapy 54:12, pages 1180-1190.
Crossref
Yi-Heng Chen, Jaw-Chin Wu, Kuei-Chun Wang, Ying-Wei Chiang, Chia-Wei Lai, Yao-Chi Chung & Yu-Chen Hu. (2005) Baculovirus-mediated production of HDV-like particles in BHK cells using a novel oscillating bioreactor. Journal of Biotechnology 118:2, pages 135-147.
Crossref
A.-L. Williamson, J.-A. Passmore & E.P. Rybicki. (2005) Strategies for the prevention of cervical cancer by human papillomavirus vaccination. Best Practice & Research Clinical Obstetrics & Gynaecology 19:4, pages 531-544.
Crossref
S. Farzana Hussain & Yvonne Paterson. (2005) What is needed for effective antitumor immunotherapy? Lessons learned using Listeria monocytogenes as a live vector for HPV-associated tumors. Cancer Immunology, Immunotherapy 54:6, pages 577-586.
Crossref
Yu-chen HU. (2005) Baculovirus as a highly efficient expression vector in insect and mammalian cells. Acta Pharmacologica Sinica 26:4, pages 405-416.
Crossref
Luis Alfonso PADILLA-PAZ. (2005) Human Papillomavirus Vaccine: History, Immunology, Current Status, and Future Prospects. Clinical Obstetrics and Gynecology 48:1, pages 226-240.
Crossref
Geoffrey P. Garnett. (2005) Role of Herd Immunity in Determining the Effect of Vaccines against Sexually Transmitted Disease. The Journal of Infectious Diseases 191:s1, pages S97-S106.
Crossref
Andrzej Palucha, Adrianna Loniewska, Subbian Satheshkumar,Anna M. Boguszewska‐Chachulska, Mahadevaiah Umashankar,Malgorzata Milner, Anne‐Lise Haenni & Handanahal Subbarao Savithri. 2005. 135 168 .
Andreas Cerny, Isabelle Hunziker, Andreas Kammer, Irmgard Pult & Olivier Engler. 2004. Handbook of Laboratory Animal Science, Second Edition. Handbook of Laboratory Animal Science, Second Edition 79 112 .
Shin-Je Ghim, Annabel Rector, Hajo Delius, John P. Sundberg, A. Bennett Jenson & Marc Van Ranst. (2004) Equine papillomavirus type 1: complete nucleotide sequence and characterization of recombinant virus-like particles composed of the EcPV-1 L1 major capsid protein. Biochemical and Biophysical Research Communications 324:3, pages 1108-1115.
Crossref
Jay A. Berzofsky, Jeffrey D. Ahlers, John Janik, John Morris, SangKon Oh, Masaki Terabe & Igor M. Belyakov. (2004) Progress on new vaccine strategies against chronic viral infections. Journal of Clinical Investigation 114:4, pages 450-462.
Crossref
Karen Manoutcharian, Alicia D??az-Orea, Goar Gevorkian, Gladis Fragoso, Gonzalo Acero, Erik Gonz?lez, Aline de Aluja, Nelly Villalobos, Eduardo G?mez-Conde & Edda Sciutto. (2004) Recombinant bacteriophage-based multiepitope vaccine against Taenia solium pig cysticercosis. Veterinary Immunology and Immunopathology 99:1-2, pages 11-24.
Crossref
Erik Rollman, Lisen Arnheim, Brian Collier, Daniel ?berg, H?kan Hall, Jonas Klingstr?m, Joakim Dillner, Diana V Pastrana, Chris B Buck, Jorma Hinkula, Britta Wahren & Stefan Schwartz. (2004) HPV-16 L1 genes with inactivated negative RNA elements induce potent immune responses. Virology 322:1, pages 182-189.
Crossref
Diana V Pastrana, Christopher B Buck, Yuk-Ying S Pang, Cynthia D Thompson, Philip E Castle, Peter C FitzGerald, Susanne Kr?ger Kjaer, Douglas R Lowy & John T Schiller. (2004) Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18. Virology 321:2, pages 205-216.
Crossref
Arvind Varsani, Anna-Lise Williamson, Debbie de Villiers, Inga Becker, Neil D. Christensen & Edward P. Rybicki. (2003) Chimeric Human Papillomavirus Type 16 (HPV-16) L1 Particles Presenting the Common Neutralizing Epitope for the L2 Minor Capsid Protein of HPV-6 and HPV-16. Journal of Virology 77:15, pages 8386-8393.
Crossref
Renée L. Finnen, Kimberly D. Erickson, Xiaojiang S. Chen & Robert L. Garcea. (2003) Interactions between Papillomavirus L1 and L2 Capsid Proteins. Journal of Virology 77:8, pages 4818-4826.
Crossref
Samir N. Khleif. (2003) Human papillomavirus therapy for the prevention and treatment of cervical cancer. Current Treatment Options in Oncology 4:2, pages 111-119.
Crossref
M. S. Campo. (2003) Papillomavirus and disease in humans and animals. Veterinary and Comparative Oncology 1:1, pages 3-14.
Crossref
Wei Zhao. (2003) No requirement of HCV 5’NCR for HCV-like particles assembly in insect cells. World Journal of Gastroenterology 9:10, pages 2226.
Crossref
Achim Schneider & Lutz Gissmann. (2003) Cervical Cancer. American Journal of Cancer 2:4, pages 253-268.
Crossref
M.Saveria Campo. (2002) Animal models of papillomavirus pathogenesis. Virus Research 89:2, pages 249-261.
Crossref
Woei Ling Peh, Kate Middleton, Neil Christensen, Philip Nicholls, Kiyofumi Egawa, Karl Sotlar, Janet Brandsma, Alan Percival, Jon Lewis, Wen Jun Liu & John Doorbar. (2002) Life Cycle Heterogeneity in Animal Models of Human Papillomavirus-Associated Disease. Journal of Virology 76:20, pages 10401-10416.
Crossref
C.Jane Dale, Xiaosong Song Liu, Robert De Rose, Damian F.J. Purcell, Jenny Anderson, Yan Xu, Graham R. Leggatt, Ian H. Frazer & Stephen J. Kent. (2002) Chimeric Human Papilloma Virus?Simian/Human Immunodeficiency Virus Virus-like-Particle Vaccines: Immunogenicity and Protective Efficacy in Macaques. Virology 301:1, pages 176-187.
Crossref
Patti E. Gravitt, Anant M. Kamath, Lynne Gaffikin, Z. Michael Chirenje, Sharita Womack & Keerti V. Shah. (2002) Human papillomavirus genotype prevalence in high-grade squamous intraepithelial lesions and colposcopically normal women from Zimbabwe. International Journal of Cancer 100:6, pages 729-732.
Crossref
Hans-Ulrich Bernard. (2001) Gene Expression of Genital Human Papillomaviruses and Considerations on Potential Antiviral Approaches. Antiviral Therapy 7:4, pages 219-237.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.